Ionising radiation and cancer risks: What have we learned from epidemiology?

By Gilbert Ethel  

International Journal of Radiation Biology, Vol. 85, Iss. 6, 2009-06 ,pp. : 467-482

Informa Healthcare

Access to resources Recommend Favorite

Changing the pathophysiology of solid tumours: The potential of TNF and other vasoactive agents

By Ten Hagen Timo L. M.   Eggermont Alexander M. M.  

International Journal of Hyperthermia, Vol. 22, Iss. 3, 2006-05 ,pp. : 241-246

Informa Healthcare

Access to resources Recommend Favorite

Strategies for the analysis of in vitro radiation sensitivity and prediction of interaction with potential radiation modifying agents

By Luttjeboer Mark   Lafleur M. Vincent M.   Kwidama Zinia J.   Rijn Johannes Van   Berg Jaap Van Den   Slotman Ben J.   Kaspers Gertjan J. L.   Cloos Jacqueline  

International Journal of Radiation Biology, Vol. 86, Iss. 6, 2010-06 ,pp. : 458-466

Informa Healthcare

Access to resources Recommend Favorite

Environmental Mutagen Society symposium on 'Risks of low dose, low dose rate exposures of ionizing radiation to humans'

By Morgan W. F.   Schwartz J. L.  

International Journal of Radiation Biology, Vol. 83, Iss. 7, 2007-01 ,pp. : 491-499

Informa Healthcare

Access to resources Recommend Favorite

Environmental Procarcinogen Hypothesis of Bladder Cancer in Humans: Dapsone Hydroxylation as a Susceptibility Risk Factor for Aggressive Bladder Cancer

By Persad R.   Fleming C.   Chern H.D.   Lesnick T.   Collins C.   Smith P.   Schwartz A.G.   Adedoyin A.   Romkes M.   Wilkinson G.R.   Branch R.A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 3, Iss. 1, 1997-01 ,pp. : 18-26

Elsevier

Access to resources Recommend Favorite